Intra-arterial clot-busting medicines don’t help after stroke thrombectomy
UC expert featured in TCTMD article
The University of Cincinnati's Pooja Khatri, MD, spoke with TCTMD about two recent trials that found administering clot-busting medications after endovascular thrombectomy does not significantly improve outcomes for patients with acute ischemic stroke. Thrombectomy is a minimally invasive stroke procedure that uses a catheter to remove a blood clot from a blood vessel in the brain to restore blood flow.
These results come after a previous trial found a large and significant benefit in administering a medication called alteplase after successful thrombectomy.
Khatri, professor, vice chair of research and division chief in the Department of Neurology and Rehabilitation Medicine at UC's College of Medicine, associate director of the UC Gardner Neuroscience Institute and codirector of NIH StrokeNet’s National Coordinating Center, who was not involved in any of the trials, said the original trial was a smaller study that ended prematurely and included patients with a wider range of results after thrombectomy.
These newer data “are promising in terms of a therapeutic strategy with thrombolysis to attack distal visualized clots and maybe impaired microcirculatory reperfusion, or the no-reflow phenomenon as we like to call it,” she said, adding, however, that “I’m disappointed that the potential effect isn’t bigger.”
Featured photo at top of UC Health's mobile stroke unit courtesy of UC Health.
Remember how to identify a stroke
Because of the quick onset of stroke, it is important to know the FAST mnemonic device that details the most common signs of stroke and how to respond:
- F: Facial drooping
- A: Arm or leg drop, or weakness in the arm or leg
- S: Speech issues, such as slurred speech or an inability to get your words out
- T: Time is of the essence; call 911 immediately
Related Stories
Recent advances may speed time to endometriosis diagnosis
March 16, 2026
The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.
Position-specific helmets may not improve protection
March 16, 2026
Local 12 highlighted a new study by biomedical engineering researchers that looked at how well new football helmets protected players from impacts that can cause concussions.
UC biologist talks about 'pearmageddon'
March 16, 2026
WLWT talks to UC biologist and Department Head Theresa Culley about invasive, nonnative Callery pear trees that are spreading across Ohio forests after they were introduced by landscapers more than 50 years ago.